Nachrichten zur Merck & Co. Inc. Aktie

JPMorgan belässt Merck KGaA auf Overweight - Ziel 150 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA nach der JPMorgan Healthcare Conference auf…

Why Mercks 32% Rally Isnt Enough to Change the Bearish View

MRK is up over 32% in three months, but declining estimates, Keytrudas upcoming LOE and Gardasil declines keep the stock…

Merck (MRK) Gains As Market Dips: What You Should Know

Merck (MRK) closed at $111.01 in the latest trading session, marking a +2.54% move from the prior day.…

Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s By Reuters

Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s…

Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s

Merck said on Monday it has raised its outlook for new growth drivers, forecasting $70 billion in revenue from these…

Merck Aktie: Goldman-Sachs-Analyst setzt auf Nachholpotenzial - Kommt jetzt die Kursjagd?

Bad Marienberg (www.aktiencheck.de) - Merck: im Aufholmodus: Goldman Sachs hebt Kursziel auf 155 Euro an - Rating "buy" bleibt, Fantasie…

Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?

The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…

Key deals this week: Merck, Glencore, CrowdStrike, Marvell Technology, Steel Dynamics and more

…

Merck in Talks to Buy Revolution Medicines Per Financial Times Report

Merck is in talks to acquire RVMD, which could bolster its oncology pipeline, according to a Financial Times report.…

Merck (MRK) Surpasses Market Returns: Some Facts Worth Knowing

Merck (MRK) concluded the recent trading session at $110.99, signifying a +2.2% move from its prior days close.…

Merck in talks to buy biotech Revolution Medicines, FT reports

Merck is in talks to buy cancer drug developer Revolution Medicines , the Financial Times reported on Thursday, citing people…

Merck & Co Aktie: Pharma-Sektor am Wendepunkt

Zürich (www.aktiencheck.de) - Merck & Co-Aktienanalyse der UBS:UBS habe das Kursziel für die Aktie von Merck & Co Inc. (ISIN:…

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

The highest-yielding stocks in the Dow are Verizon, Chevron, and Merck, but should you buy any of them?…

Merck & Co Aktie 2026: Phase-3-Daten und CADENCE-Studie im Fokus der Analysten

San Francisco (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Wells Fargo:Die Analysten von Wells Fargo haben die Aktie von Merck &…

Merck (MRK) Laps the Stock Market: Heres Why

The latest trading day saw Merck (MRK) settling at $106.45, representing a +1.13% change from its previous close.…

Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook

…

Merck: Framework For Success

…

Merck: A Post-2028 Slowdown Doesnt Kill The Long-Term Thesis

…

Why Merck (MRK) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Why Merck (MRK) Outpaced the Stock Market Today

The latest trading day saw Merck (MRK) settling at $106.45, representing a +1.34% change from its previous close.…

Pharmakonzern: Merck erhält Zulassung für Tumormittel in China

Das Tumormittel Pimicotinib soll das erste Medikament sein, das in China die Zulassung zur Behandlung spezieller Tumore erhalten hat. Auch…

Aktien von Merck, Roche, Novartis & Co.: US-Regierung erzielt Preisdeal mit neun Pharmafirmen

Am Freitagabend teilte die US-Regierung mit, dass sie mit neun internationalen Pharmafirmen, darunter die Roche-Tochter Genentech und Novartis, eine…

Notable analyst calls this week: Paypal, Rivian and Merck among top picks

…

Better Buy in 2026: Pfizer or Merck?

This year has been one to forget for these pharmaceutical giants.…

Heres Why Merck (MRK) is a Strong Growth Stock

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…

Mercks Deep Pipeline And Cash Flow Strength Support The Bull Case

…

Top Research Reports for NVIDIA, Netflix & Merck

New research highlights NVIDIAs AI-driven growth, Netflixs ad-tier momentum and Mercks pipeline progress, while microcaps also make the cut.…

Merck (MRK) Rises Higher Than Market: Key Facts

In the latest trading session, Merck (MRK) closed at $100.69, marking a +1.52% move from the previous day.…

Merck & Co Aktie: Upgrade von BMO - Keytruda-Nachfolgeprodukte im Fokus

Toronto (www.aktiencheck.de) - Merck-Aktienanalyse von BMO Capital Markets:Die Analysten von BMO Capital haben die Aktie von Merck & Co Inc.…

Merck Aktie: Kurz vor starkem Kaufsignal!

Kulmbach (www.aktiencheck.de) - Merck-Aktienanalyse von "Der Aktionär":Andreas Agly vom Anlegermagazin "Der Aktionär" nimmt im "Der Aktionär TV" die Aktie der…

Merck, Oracle among market cap stock movers on Tuesday By Investing.com

Merck, Oracle among market cap stock movers on Tuesday…

Eli Lilly or Merck: Where Should Investors Put Their Money?

LLYs explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer…

LGND: 2025 Analyst Day

By John Vandermosten, CFANASDAQ:LGNDREAD THE FULL LGND RESEARCH REPORTLigand Pharmaceuticals, Inc. (NASDAQ:LGND) held its 2025 analyst day on December 9th,…

Merck & Co Aktie: Analyst hebt Kursziel an - Regulierung verliert 2026 an Gewicht

New York (www.aktiencheck.de) - Merck-Aktienanalyse von Morgan Stanley:Der Analyst Terence Flynn von Morgan Stanley hat das Kursziel für die Aktie…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 150 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA auf "Overweight" mit einem Kursziel von…

Can MRKs New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?

Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytrudas 2028 LOE nears.…

Merck (MRK) Laps the Stock Market: Heres Why

Merck (MRK) closed at $99.01 in the latest trading session, marking a +1.42% move from the prior day.…

FDA approves Merck drug for decimated U.S. cattle herds to stop screwworm

Theres hope for U.S. cattle ranchers in the battle to stop the spread of screwworm at a time of decimated…

MRK Stock Trading Above 200- & 50-Day SMA for 2 Months: Time to Buy?

Merck holds bullish momentum as pipeline advances and major deals offset vaccine weakness and Keytruda risks.…

Exclusive: US FDA launches fresh safety scrutiny of approved RSV therapies for infants

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for…

Mercks Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?

After a long hiatus, why are the bulls so willing to buy in now?…

Merck & Co.: Pharmariese wird dank starker Pipeline zum Überflieger! Merck entfesselt sein Kurspotenzial!

Seit Wochen zeigt sich der Sektor "Healthcare" in einer starken Verfassung. Mit über 7 % Kursgewinn setzt er sich in…

Merck & Co., Inc. (MRK) Presents at Evercore 8th Annual Healthcare Conference Transcript

…

Why Merck (MRK) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Heres Why Merck (MRK) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Merck: Excellence Across The Board

…

AstraZeneca or Merck: Which Oncology Giant Has the Edge?

AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.…

AMD, Merck among market cap stock movers on Tuesday By Investing.com

AMD, Merck among market cap stock movers on Tuesday…

Schlussglocke: Dow & Co mit starkem Auftakt, Merck und Alphabet haussieren

Die Hoffnung auf eine baldige weitere Leitzinssenkung hat am Montag an den US-Börsen die konjunktursensiblen Technologiewerte beflügelt. Als Auslöser galten…

Merck upgraded at Wells Fargo as analyst sees ‘a future beyond Keytruda’ By Investing.com

Merck upgraded at Wells Fargo as analyst sees ‘a future beyond Keytruda’…